Dendritic cells - Importance in allergy

Allergology International

Volumn 56, Issue 3, 2007, Pages 201-208

  Aiba, Setsuya ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Asthma; Atopic dermatitis; Contact dermatitis; Th1 Th2

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIGEN; HAPTEN; MITOGEN ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN;

ALLERGY; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ASTHMA; ATOPIC DERMATITIS; ATOPY; CELL ACTIVATION; CELL FUNCTION; CELL MATURATION; CELL MIGRATION; CONTACT ALLERGY; DENDRITIC CELL; EFFECTOR CELL; ENZYME ACTIVATION; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; KERATINOCYTE; LYMPH NODE; LYMPHATIC DRAINAGE; NONHUMAN; OXIDATION REDUCTION STATE; PAPULOVESICULAR RASH; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; SKIN MANIFESTATION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

EID: 34548831047     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.R-07-147     Document Type: Review

References (91)

1. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 1991;9:271-296.
2. Romani N, Koide S, Crowley M et al. Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells. J. Exp. Med. 1989;169:1169-1178.
3. Garrett WS, Chen LM, Kroschewski R et al. Developmental control of endocytosis in dendritic cells by Cdc42. Cell 2000;102:325-334.
4. Stossel H, Koch F, Kampgen E et al. Disappearance of certain acidic organelles (endosomes and Langerhans cell granules) accompanies loss of antigen processing capacity upon culture of epidermal Langerhans cells. J. Exp. Med. 1990;172:1471-1482.
5. Kampgen E, Koch N, Koch F et al. Class II major histocompatibility complex molecules of murine dendritic cells: synthesis, sialylation of invariant chain, and antigen processing capacity are down-regulated upon culture. Proc. Natl. Acad. Sci. U.S.A. 1991;88:3014-3018.
6. Steinman RM. Some interfaces of dendritic cell biology. APMIS 2003;111:675-697.
7. Matzinger P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 1994;12:991-1045.
8. Gallucci S, Matzinger P. Danger signals: SOS to the immune system. Curr. Opin. Immunol. 2001;13:114-119.
9. Sauter B, Albert ML, Francisco L et al. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 2000;191:423-434.
10. Kawai T, Akira S. TLR signaling. Cell Death Differ. 2006; 13:816-825.
11. Gerosa F, Baldani-Guerra B, Nisii C et al. Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 2002;195:327-333.
12. Piccioli D, Sbrana S, Melandri E, Valiante NM. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J. Exp. Med. 2002;195:335-341.
13. Leslie DS, Vincent MS, Spada FM et al. CD1-mediated gamma/delta T cell maturation of dendritic cells. J. Exp. Med. 2002;196:1575- 1584.
14. Fujii S, Shimizu K, Smith C, Bonifaz L, Steinman RM. Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J. Exp. Med. 2003;198:267-279.
15. van Kooten C, Banchereau J. CD40-CD40 ligand. J. Leukoc. Biol. 2000;67:2-17.
16. Caux C, Massacrier C, Vanbervliet B et al. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 1994;180:1263-1272.
17. Cella M, Scheidegger D, Palmer-Lehmann K et al. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 1996;184:747-752.
18. Koch F, Stanzl U, Jennewein P et al. High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J. Exp. Med. 1996;184:741-746.
19. French RR, Chan HT, Tutt AL, Glennie MJ. CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help. Nat. Med. 1999;5: 548-553.
20. Rissoan MC, Soumelis V, Kadowaki N et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science 1999;283:1183-1186.
21. Schoenberger SP, Toes RE, van der Voort EI, Offringa R, Melief CJ. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 1998;393:480-483.
22. Behrens GM, Li M, Davey GM et al. Helper requirements for generation of effector CTL to islet beta cell antigens. J. Immunol. 2004;172:5420-5426.
23. Regnault A, Lankar D, Lacabanne V et al. Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J. Exp. Med. 1999;189:371-380.
24. Kalergis AM, Ravetch JV. Inducing tumor immunity through the selective engagement of activating Fcgamma receptors on dendritic cells. J. Exp. Med. 2002;195:1653-1659.
25. Schuurhuis DH, Ioan-Facsinay A, Nagelkerken B et al. Antigen-antibody immune complexes empower dendritic cells to efficiently prime specific CD8+ CTL responses in vivo. J. Immunol. 2002;168:2240- 2246.
26. Aiba S, Katz SI. Phenotypic and functional characteristics of in vivo -activated Langerhans cells. J. Immunol. 1990; 145:2791-2796.
27. Ozawa H, Nakagawa S, Tagami H, Aiba S. Interleukin-1 beta and granulocyte-macrophage colony-stimulating factor mediate Langerhans cell maturation differently. J. Invest. Dermatol. 1996;106:441-445.
28. Enk AH, Katz SI. Early molecular events in the induction phase of contact sensitivity. Proc. Natl. Acad. Sci. U. S. A. 1992;89:1398-1402.
29. Aiba S, Terunuma A, Manome H, Tagami H. Dendritic cells differently respond to haptens and irritants by their production of cytokines and expression of co-stimulatory molecules. Eur. J. Immunol. 1997;27:3031-3038.
30. Geissmann F, Prost C, Monnet JP et al. Transforming growth factor beta1, in the presence of granulocyte/ macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J. Exp. Med. 1998; 187:961-966.
31. Aiba S, Manome H, Yoshino Y, Tagami H. In vitro treatment of human TGF-beta1-treated monocyte-derived dendritic cells with haptens can induce the phenotypic and functional changes similar to epidermal Langerhans cells in the initiation phase of allergic contact sensitivity reaction. Immunology 2000;101:68-75.
32. Schwarzenberger K, Udey MC. Contact allergens and epidermal proinflammatory cytokines modulate Langerhans cell E-cadherin expression in situ. J. Invest. Dermatol. 1996;106:553-558.
33. Ebner S, Lenz A, Reider D et al. Expression of maturation-/migration-related molecules on human dendritic cells from blood and skin. Immunobiol. 1998;198: 568-587.
34. Kobayashi Y. Langerhans' cells produce type IV collagenase (MMP-9) following epicutaneous stimulation with haptens. Immunology 1997;90:496-501.
35. Staquet MJ, Levarlet B, Dezutter-Dambuyant C, Schmitt D. Human epidermal Langerhans cells express beta 1 integrins that mediate their adhesion to laminin and fibronectin. J. Invest. Dermatol. 1992;99:12S-14S.
36. Aiba S, Nakagawa S, Ozawa H et al. Up-regulation of alpha 4 integrin on activated Langerhans cells: analysis of adhesion molecules on Langerhans cells relating to their migration from skin to draining lymph nodes. J. Invest. Dermatol. 1993;100:143-147.
37. Weiss JM, Sleeman J, Renkl AC et al. An essential role for CD44 variant isoforms in epidermal Langerhans cell and blood dendritic cell function. J. Cell Biol. 1997;137:1137-1147.
38. Dieu MC, Vanbervliet B, Vicari A et al. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med. 1998;188:373-386.
39. Saeki H, Moore AM, Brown MJ, Hwang ST. Cutting edge: secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J. Immunol. 1999;162:2472-2475.
40. Sallusto F, Schaerli P, Loetscher P et al. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J. Immunol. 1998;28:2760-2769.
41. Kuhn U, Brand P, Willemsen J et al. Induction of tyrosine phosphorylation in human MHC class II-positive antigen-presenting cells by stimulation with contact sensitizers. J. Immunol. 1998;160:667- 673.
42. Arrighi JF, Rebsamen M, Rousset F, Kindler V, Hauser C. A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-alpha, and contact sensitizers. J. Immunol. 2001;166:3837-3845.
43. Aiba S, Manome H, Nakagawa S et al. p38 mitogen-activated protein kinase and extracellular signal-regulated kinases play distinct roles in the activation of dendritic cells by two representative haptens, NiCl2 and DNCB. J. Invest. Dermatol. 2003;120:390-398.
44. Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free. Rad. Biol. Med. 2001;30: 1191-1212.
45. Nordberg J, Zhong L, Holmgren A, Arner ES. Mammalian thioredoxin reductase is irreversibly inhibited by dinitrohalobenzenes by alkylation of both the redox active selenocysteine and its neighboring cysteine residue. J. Biol. Chem. 1998;273:10835-10842.
46. Saitoh M, Nishitoh H, Fujii M et al. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 1998;17:2596-2606.
47. Lazarowski ER, Homolya L, Boucher RC, Harden TK. Direct demonstration of mechanically induced release of cellular UTP and its implication for uridine nucleotide receptor activation. J. Biol. Chem. 1997;272:24348- 24354.
48. Roman RM, Wang Y, Lidofsky SD et al. Hepatocellular ATP-binding cassette protein expression enhances ATP release and autocrine regulation of cell volume. J. Biol. Chem. 1997;272:21970-21976.
49. Cotrina ML, Lin JH, Alves-Rodrigues A et al. Connexins regulate calcium signaling by controlling ATP release. Proc. Natl. Acad. Sci. U. S. A. 1998;95:15735-15740.
50. Hamada K, Takuwa N, Yokoyama K, Takuwa Y. Stretch activates Jun N-terminal kinase/stress-activated protein kinase in vascular smooth muscle cells through mechanisms involving autocrine ATP stimulation of purinoceptors. J. Biol. Chem. 1998;273:6334-6340.
51. Mitchell CH, Carre DA, McGlinn AM, Stone RA, Civan MM. A release mechanism for stored ATP in ocular ciliary epithelial cells. Proc. Natl. Acad. Sci. U. S. A. 1998;95: 7174-7178.
52. Imai M, Goepfert C, Kaczmarek E, Robson SC. CD39 modulates IL-1 release from activated endothelial cells. Biochem. Biophys. Res. Commun. 2000;270:272-278.
53. Ferrari D, La Sala A, Chiozzi P et al. The P2 purinergic receptors of human dendritic cells: identification and coupling to cytokine release. FASEB J. 2000;14:2466-2476.
54. Mizumoto N, Mummert ME, Shalhevet D, Takashima A. Keratinocyte ATP release assay for testing skin-irritating potentials of structurally diverse chemicals. J. Invest. Dermatol. 2003;121:1066-1072.
55. la Sala A, Ferrari D, Di Virgilio F et al. Alerting and tuning the immune response by extracellular nucleotides. J. Leukoc. Biol. 2003;73:339-343.
56. Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol. Rev. 1998;50:413-492.
57. Williams M, Jarvis MF. Adenosine antagonists as potential therapeutic agents. Pharmacol. Biochem. Behav. 1988; 29:433-441.
58. Williams M, Jarvis MF. Purinergic and pyrimidinergic receptors as potential drug targets. Biochem. Pharmacol. 2000;59:1173-1185.
59. la Sala A, Ferrari D, Corinti S et al. Extracellular ATP induces a distorted maturation of dendritic cells and inhibits their capacity to initiate Th1 responses. J. Immunol. 2001;166:1611-1617.
60. Wilkin F, Duhant X, Bruyns C et al. The P2Y11 receptor mediates the ATP-induced maturation of human monocyte-derived dendritic cells. J. Immunol. 2001;166: 7172-7177.
61. Grabbe S, Steinert M, Mahnke K et al. Dissection of antigenic and irritative effects of epicutaneously applied haptens in mice. Evidence that not the antigenic component but nonspecific proinflammatory effects of haptens determine the concentration-dependent elicitation of allergic contact dermatitis. J. Clin. Invest. 1996;98:1158-1164.
62. Tang A, Amagai M, Granger LG, Stanley JR, Udey MC. Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature 1993;361:82-85.
63. Kobayashi Y, Matsumoto M, Kotani M, Makino T. Possible involvement of matrix metalloproteinase-9 in Langerhans cell migration and maturation. J. Immunol. 1999; 163:5989-5993.
64. Caux C, Ait-Yahia S, Chemin K et al. Dendritic cell biology and regulation of dendritic cell trafficking by chemokines. Springer Semin. Immunopathol. 2000;22: 345-369.
65. Robbiani DF, Finch RA, Jager D et al. The leukotriene C (4) transporter MRP1 regulates CCL19 (MIP-3beta, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell 2000;103:757-768.
66. Kabashima K, Saji T, Murata T et al. The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. J. Clin. Invest. 2002;109: 883-893.
67. Scandella E, Men Y, Legier DF et al. CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2. Blood 2004;103:1595-1601.
68. Legler DF, Krause P, Scandella E, Singer E, Groettrup M. Prostaglandin E2 is generally required for human dendritic cell migration and exerts its effect via EP2 and EP4 receptors. J. Immunol. 2006;176:966-973.
69. Partida-Sanchez S, Goodrich S, Kusser K et al. Regulation of dendritic cell trafficking by the ADP-ribosyl cyclase CD38: impact on the development of humoral immunity. Immunity 2004;20:279-291.
70. Qu C, Edwards EW, Tacke F et al. Role of CCR8 and other chemokine pathways in the migration of monocyte-derived dendritic cells to lymph nodes. J. Exp. Med. 2004; 200:1231-1241.
71. Schulz O, Edwards AD, Schito M et al. CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal. Immunity 2000; 13:453-462.
72. Kalinski P, Hilkens CM, Wierenga EA, Kapsenberg ML. T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol. Today 1999; 20:561-567.
73. Langenkamp A, Messi M, Lanzavecchia A, Sallusto F. Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells. Nat. Immunol 2000; 1:311-316.
74. Albanesi C, Scarponi C, Cavani A et al. Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-gamma- and interleukin-4-induced activation of human keratinocytes. J. Invest. Dermatol. 2000; 115:81-87.
75. Albanesi C, Scarponi C, Sebastiani S et al. IL-4 enhances keratinocyte expression of CXCR3 agonistic chemokines. J. Immunol. 2000;165:1395-1402.
76. Albanesi C, Scarponi C, Sebastiani S et al. A cytokine-to- chemokine axis between T lymphocytes and keratinocytes can favor Th1 cell accumulation in chronic inflammatory skin diseases. J. Leukoc. Biol. 2001;70:617-623.
77. Traidl C, Sebastiani S, Albanesi C et al. Disparate cytotoxic activity of nickel-specific CD8+ and CD4+ T cell subsets against keratinocytes. J. Immunol. 2000;165:3058-3064.
78. Trautmann A, Akdis M, Kleemann D et al. T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis.[comment]. J. Clin. Invest. 2000;106:25-35.
79. Cella M, Facchetti F, Lanzavecchia A, Colonna M. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat. Immunol. 2000;1:305-310.
80. Gutzmer R, Langer K, Usewski M et al. Expression and function of histamine receptors 1 and 2 on human monocyte-derived dendritic cells. J. Allergy Clin. Immunol. 2002;109:524-531.
81. Mazzoni A, Young HA, Spitzer JH, Visintin A, Segal DM. Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization. J. Clin. Invest. 2001;108:1865-1873.
82. Caron G, Delneste Y, Roelandts E et al. Histamine polarizes human dendritic cells into Th2 cell-promoting effector dendritic cells. J. Immunol. 2001;167:3682-3686.
83. Sims JE, Williams DE, Morrissey PJ et al. Molecular cloning and biological characterization of a novel murine lymphoid growth factor. J. Exp. Med. 2000;192:671-680.
84. Pandey A, Ozaki K, Baumann H et al. Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin. Nat. Immunol. 2000;1:59-64.
85. Park LS, Martin U, Garka K et al. Cloning of the murine thymic stromal lymphopoietin (TSLP) receptor: Formation of a functional heteromeric complex requires interleukin 7 receptor. J. Exp. Med. 2000;192:659-670.
86. Fujio K, Nosaka T, Kojima T et al. Molecular cloning of a novel type 1 cytokine receptor similar to the common gamma chain. Blood 2000;95:2204-2210.
87. Soumelis V, Reche PA, Kanzler H et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nature Immunol. 2002;3:673-680.
88. Ito T, Wang YH, Duramad O et al. TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J. Exp. Med. 2005;202:1213-1223.
89. Ying S, O'Connor B, Ratoff J et al. Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity. J. Immunol. 2005;174:8183-8190.
90. Yoo J, Omori M, Gyarmati D et al. Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin. J. Exp. Med. 2005;202:541-549.
91. Zhou B, Comeau MR, De Smedt T et al. Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice. Nat. Immunol. 2005;6:1047-1053.